Dare Bioscience, Inc. Investment Income, Interest
Dare Bioscience, Inc. (DARE) reported Investment Income, Interest of $20.00 thousand for the 3-month period ending 2017-06-30, per its 10-Q filed 2017-08-14.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2017-08-14
- Dare Bioscience, Inc. investment income, interest for the quarter ending 2017-06-30 was $20.00K, a 20.00% decline year-over-year.
- Dare Bioscience, Inc. investment income, interest for the quarter ending 2017-03-31 was $33.00K, a 106.25% increase year-over-year.
- Dare Bioscience, Inc. investment income, interest for the quarter ending 2016-12-31 was $20.00K, a 900.00% increase year-over-year.
- Dare Bioscience, Inc. investment income, interest for the quarter ending 2016-09-30 was $25.00K, a 525.00% increase year-over-year.
- Dare Bioscience, Inc. investment income, interest for fiscal 2016 was $86.00K, a 760.00% increase from fiscal 2015.
- Dare Bioscience, Inc. investment income, interest for fiscal 2015 was $10.00K, a 11.11% increase from fiscal 2014.
- Dare Bioscience, Inc. investment income, interest for fiscal 2014 was $9.00K, a 350.00% increase from fiscal 2013.
- Dare Bioscience, Inc. investment income, interest for fiscal 2013 was $2.00K, a 0.00% change from fiscal 2012.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month | Investment Income, Interest 100 month |
|---|---|---|---|---|---|
| 2017-06-30 | $20.00K 10-Q · filed 2017-08-14 | $53.00K 10-Q · filed 2017-08-14 | $73.00K derived: sum of 3 quarters · filed 2017-08-14 | $98.00K derived: sum of 4 quarters · filed 2017-08-14 | |
| 2017-03-31 | $33.00K 10-Q · filed 2017-05-12 | $53.00K derived: sum of 2 quarters · filed 2017-06-13 | $78.00K derived: sum of 3 quarters · filed 2017-06-13 | $103.00K derived: sum of 4 quarters · filed 2017-08-14 | |
| 2016-12-31 | $20.00K 10-K/A · filed 2017-06-13 | $45.00K derived: sum of 2 quarters · filed 2017-06-13 | $70.00K derived: sum of 3 quarters · filed 2017-08-14 | $86.00K 10-K/A · filed 2017-06-13 | |
| 2016-09-30 | $25.00K 10-K/A · filed 2017-06-13 | $50.00K derived: sum of 2 quarters · filed 2017-08-14 | $66.00K 10-Q · filed 2016-11-03 | $68.00K derived: sum of 4 quarters · filed 2017-08-14 | |
| 2016-06-30 | $25.00K 10-Q · filed 2017-08-14 | $41.00K 10-Q · filed 2017-08-14 | $43.00K derived: sum of 3 quarters · filed 2017-08-14 | $47.00K derived: sum of 4 quarters · filed 2017-08-14 | |
| 2016-03-31 | $16.00K 10-K/A · filed 2017-06-13 | $18.00K derived: sum of 2 quarters · filed 2017-06-13 | $22.00K derived: sum of 3 quarters · filed 2017-06-13 | $23.00K derived: sum of 4 quarters · filed 2017-06-13 | |
| 2015-12-31 | $2.00K 10-K/A · filed 2017-06-13 | $6.00K derived: sum of 2 quarters · filed 2017-06-13 | $7.00K derived: sum of 3 quarters · filed 2017-06-13 | $10.00K 10-K/A · filed 2017-06-13 | |
| 2015-09-30 | $4.00K 10-K/A · filed 2017-06-13 | $5.00K derived: sum of 2 quarters · filed 2017-06-13 | $8.00K 10-Q · filed 2016-11-03 | $12.00K derived: sum of 4 quarters · filed 2017-06-13 | |
| 2015-06-30 | $1.00K 10-K/A · filed 2017-06-13 | $4.00K 10-Q · filed 2016-08-04 | $8.00K derived: sum of 3 quarters · filed 2017-06-13 | $10.00K derived: sum of 4 quarters · filed 2017-06-13 | |
| 2015-03-31 | $3.00K 10-K/A · filed 2017-06-13 | $7.00K derived: sum of 2 quarters · filed 2017-06-13 | $9.00K derived: sum of 3 quarters · filed 2017-06-13 | $11.00K derived: sum of 4 quarters · filed 2017-06-13 | |
| 2014-12-31 | $4.00K 10-K · filed 2016-03-10 | $6.00K derived: sum of 2 quarters · filed 2016-03-10 | $8.00K derived: sum of 3 quarters · filed 2016-03-10 | $9.00K 10-K/A · filed 2017-06-13 | |
| 2014-09-30 | $2.00K 10-K · filed 2016-03-10 | $4.00K derived: sum of 2 quarters · filed 2016-03-10 | $5.00K 10-Q · filed 2015-11-16 | $6.00K derived: sum of 4 quarters · filed 2016-03-10 | |
| 2014-06-30 | $2.00K 10-K · filed 2016-03-10 | $3.00K 10-Q · filed 2015-08-06 | $4.00K derived: sum of 3 quarters · filed 2016-03-10 | $4.00K derived: sum of 4 quarters · filed 2016-03-10 | |
| 2014-03-31 | $1.00K 10-K · filed 2016-03-10 | $2.00K derived: sum of 2 quarters · filed 2016-03-10 | $2.00K derived: sum of 3 quarters · filed 2016-03-10 | $2.00K derived: sum of 4 quarters · filed 2016-03-10 | $685.00K 10-Q · filed 2014-05-27 |
| 2013-12-31 | $1.00K 10-K · filed 2015-03-19 | $1.00K derived: sum of 2 quarters · filed 2015-03-19 | $1.00K derived: sum of 3 quarters · filed 2015-03-19 | $2.00K 10-K · filed 2016-03-10 | |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $0.00 derived: sum of 2 quarters · filed 2014-11-13 | $1.00K 10-Q · filed 2014-11-13 | ||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-K 3 month · filed 2014-08-12 | $1.00K 10-Q · filed 2014-08-12 | |||
| 2013-03-31 | $1.00K 10-K · filed 2015-03-19 | ||||
| 2012-12-31 | $2.00K 10-K · filed 2015-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |